Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV003448657 | SCV004176417 | likely pathogenic | Congenital myasthenic syndrome 5 | 2023-03-01 | criteria provided, single submitter | clinical testing | The invariant splice acceptor c.955-2A>C variant in COLQ gene has not been reported previously as a pathogenic variant nor a benign variant, to our knowledge. The c.955-2A>C variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. This variant has not been reported to the ClinVar database. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic. |
Baylor Genetics | RCV003448657 | SCV004214448 | pathogenic | Congenital myasthenic syndrome 5 | 2024-02-08 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV004999935 | SCV005621846 | pathogenic | not provided | 2024-02-27 | criteria provided, single submitter | clinical testing | This variant is expected to maintain the transcript reading frame, however, it may still disrupt protein function. This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) This variant segregates with disease in at least one family. |
Fulgent Genetics, |
RCV003448657 | SCV005664983 | likely pathogenic | Congenital myasthenic syndrome 5 | 2024-05-16 | criteria provided, single submitter | clinical testing |